Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 94 of 1714:
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type IX, alpha CELECOXIB Sodium Channel, Site 2 62% 16.854uM 15.111uM View
sodium channel, voltage-gated, type VII, alpha CELECOXIB Sodium Channel, Site 2 62% 16.854uM 15.111uM View
amiloride-sensitive cation channel 5, intestinal CELECOXIB Sodium Channel, Site 2 62% 16.854uM 15.111uM View
sodium channel, voltage-gated, type I, beta PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha PENTAMIDINE Sodium Channel, Site 2 62% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a CYPROHEPTADINE Serotonin 5-HT3 62% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b CYPROHEPTADINE Serotonin 5-HT3 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 1 MYRTECAINE Potassium Channel HERG 65% 5.9024uM 4.8357uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 MYRTECAINE Potassium Channel HERG 65% 5.9024uM 4.8357uM View
potassium voltage-gated channel, subfamily H, member 8 MYRTECAINE Potassium Channel HERG 65% 5.9024uM 4.8357uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 MYRTECAINE Potassium Channel HERG 65% 5.9024uM 4.8357uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 MYRTECAINE Potassium Channel HERG 65% 5.9024uM 4.8357uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 MYRTECAINE Potassium Channel HERG 65% 5.9024uM 4.8357uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 MYRTECAINE Potassium Channel HERG 65% 5.9024uM 4.8357uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 MYRTECAINE Potassium Channel HERG 65% 5.9024uM 4.8357uM View
potassium voltage-gated channel, subfamily H, member 8 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 SERTRALINE Potassium Channel HERG 65% 8.3173uM 6.8141uM View
Cytochrom P450-2D6 monooxygenase FLUNARIZINE CYP450-2D6 Inhibition 65% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase IODOQUINOL CYP450-1A2 Inhibition 65% NoneNone NoneNone View
opioid receptor, sigma 1 AMBROXOL Sigma1 65% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DIMENHYDRINATE Serotonin Transporter 65% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 TRIMETAZIDINE Serotonin Transporter 65% NoneNone NoneNone View
opioid receptor, sigma 1 HYDROXYCHLOROQUINE Sigma1 65% NoneNone NoneNone View
mu-opioid receptor MOR THIORIDAZINE Opiate mu 65% NoneNone NoneNone View
cholinergic receptor, muscarinic 2 CINNARIZINE Muscarinic M2 65% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D IODOQUINOL Glutamate, NMDA, Phencyclidine 65% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C IODOQUINOL Glutamate, NMDA, Phencyclidine 65% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B IODOQUINOL Glutamate, NMDA, Phencyclidine 65% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A IODOQUINOL Glutamate, NMDA, Phencyclidine 65% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) IODOQUINOL Glutamate, NMDA, Phencyclidine 65% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B IODOQUINOL Glutamate, NMDA, Phencyclidine 65% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase DOXEPIN CYP450-2D6 Inhibition 65% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) ANASTROZOLE CYP450-2C9 Inhibition 65% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 ANASTROZOLE CYP450-2C9 Inhibition 65% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 AMITRAZ Adrenergic, Norepinephrine Transporter 65% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 ETHYLESTRENOL Muscarinic M4 65% NoneNone NoneNone View
adrenergic receptor, alpha 1a METHYLERGONOVINE Adrenergic alpha1A 65% NoneNone NoneNone View
histamine receptor H 1 BUSPIRONE Histamine H1, Central 65% NoneNone NoneNone View
histamine receptor H 1 ERGOTAMINE Histamine H1, Central 65% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 TERCONAZOLE CYP450-3A4 Inhibition 65% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A TERBINAFINE Serotonin 5-HT2A 65% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 TERCONAZOLE Adenosine Transporter 65% 12.383uM 4.236uM View
concentrative Na+ nucleoside cotransporter (DBSS) TERCONAZOLE Adenosine Transporter 65% 12.383uM 4.236uM View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 TERCONAZOLE Adenosine Transporter 65% 12.383uM 4.236uM View
adenine nucleotide translocase (DBSS) (Non-specific probe) TERCONAZOLE Adenosine Transporter 65% 12.383uM 4.236uM View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 TERCONAZOLE Adenosine Transporter 65% 12.383uM 4.236uM View
melanocortin 5 receptor PROCHLORPERAZINE Melanocortin MC5 65% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) DESLORATADINE Adrenergic alpha1D 65% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 GUANABENZ Serotonin 5-HT6 65% NoneNone NoneNone View
adenosine A1 receptor GW-1929 Adenosine A1 65% 14.966uM 8.73uM View
epidermal growth factor receptor ECONAZOLE Protein Tyrosine Kinase, EGF Receptor 65% 32.404uM NoneNone View
epidermal growth factor receptor MICONAZOLE Protein Tyrosine Kinase, EGF Receptor 65% 29.256uM NoneNone View
phosphodiesterase 4C, cAMP-specific LY-294002 Phosphodiesterase PDE4 64% 10.404uM NoneNone View
phosphodiesterase 4D LY-294002 Phosphodiesterase PDE4 64% 10.404uM NoneNone View
phosphodiesterase 4B, cAMP specific LY-294002 Phosphodiesterase PDE4 64% 10.404uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, gamma subunit 7 ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, gamma subunit 6 ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, gamma subunit 5 ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, gamma subunit 4 ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, gamma subunit 3 ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, gamma subunit 2 ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, gamma subunit 1 ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, beta 4 subunit ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, beta 3 subunit ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, beta 2 subunit ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, alpha 1F subunit ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit ETHINYLESTRADIOL Calcium Channel Type L, Benzothiazepine 64% 15.42uM 13.706uM View
melanocortin 5 receptor SULOCTIDIL Melanocortin MC5 64% NoneNone NoneNone View
thromboxane A synthase 1 GLYBURIDE Thromboxane Synthetase 64% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) GLYBURIDE Thromboxane Synthetase 64% NoneNone NoneNone View
opioid receptor, sigma 1 CYCLIZINE Sigma1 64% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 CYCLIZINE Serotonin 5-HT6 64% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) IMATINIB Protein Tyrosine Kinase, Lck 64% NoneNone NoneNone View
opioid receptor, delta 1 CINNARIZINE Opiate delta 64% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase MOCLOBEMIDE CYP450-2C19 Inhibition 64% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase 4-NONYLPHENOL CYP450-2C19 Inhibition 64% NoneNone NoneNone View
opioid receptor, kappa 1 BITHIONOL Opiate kappa 64% NoneNone NoneNone View
adrenergic receptor, alpha 2b DOBUTAMINE Adrenergic alpha2C 64% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) DOBUTAMINE Adrenergic alpha2C 64% NoneNone NoneNone View
adrenergic receptor, alpha 1a AMITRAZ Adrenergic alpha1A 64% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific CLOSANTEL Phosphodiesterase PDE5 64% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific CLOSANTEL Phosphodiesterase PDE5 64% NoneNone NoneNone View
adrenergic receptor, beta 3 ERGOTAMINE Adrenergic beta3 64% NoneNone NoneNone View
cholinergic receptor, muscarinic 2 TERCONAZOLE Muscarinic M2 64% 12.909uM 4.59uM View
calcium channel, voltage-dependent, gamma subunit 8 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, gamma subunit 7 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, gamma subunit 6 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, gamma subunit 5 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, gamma subunit 4 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, gamma subunit 3 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, gamma subunit 2 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, gamma subunit 1 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, beta 4 subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, beta 3 subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, beta 2 subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
interleukin 1 receptor, type I AURANOFIN Interleukin IL-1 alpha 9% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
estrogen receptor 1 STANOLONE Estrogen ERalpha 63% NoneNone NoneNone View
estrogen receptor 1 STANOLONE Estrogen ERalpha 63% NoneNone NoneNone View
cholinergic receptor, muscarinic 2 TACRINE Muscarinic M2 63% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B TACRINE Serotonin 5-HT2B 63% NoneNone NoneNone View
opioid receptor, kappa 1 METERGOLINE Opiate kappa 63% NoneNone NoneNone View
Sigma-2 Receptor METERGOLINE Sigma2 63% NoneNone NoneNone View
opioid receptor, sigma 1 CYPROHEPTADINE Sigma1 63% NoneNone NoneNone View
androgen receptor ECONAZOLE Testosterone 63% 10.125uM 6.75uM View
acetylcholinesterase (YT blood group) BENZO[A]PYRENE Acetylcholinesterase 63% 28uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase BENZO[A]PYRENE Acetylcholinesterase 63% 28uM NoneNone View
acetylcholinesterase BENZO[A]PYRENE Acetylcholinesterase 63% 28uM NoneNone View
sodium channel, voltage-gated, type IX, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type VII, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
amiloride-sensitive cation channel 5, intestinal DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type III, beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type XI, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type I, beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type V, alpha polypeptide DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type II, beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, nonvoltage-gated 1 alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, nonvoltage-gated 1 gamma DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, nonvoltage-gated 1 beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type XI, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, nonvoltage-gated 1, gamma DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, nonvoltage-gated 1, delta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, nonvoltage-gated 1 alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type X, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type IX, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage gated, type VIII, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type VII, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type IV, beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type IV, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type III, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
adrenergic receptor, alpha 2a DIPHENHYDRAMINE Adrenergic alpha2A 62% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B S-(-)-PROPRANOLOL Serotonin 5-HT1B 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase LORATADINE CYP450-2D6 Inhibition 62% NoneNone NoneNone View
adrenergic receptor, alpha 2a 2-ACETYLAMINOFLUORENE Adrenergic alpha2A 62% 21.061uM 7.898uM View
5-hydroxytryptamine (serotonin) receptor 2B 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Serotonin 5-HT2B 62% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B 1-NAPHTHYL ISOTHIOCYANATE Serotonin 5-HT2B 62% 25.158uM 16.009uM View
thromboxane A synthase 1 ITRACONAZOLE Thromboxane Synthetase 62% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) ITRACONAZOLE Thromboxane Synthetase 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 GUANETHIDINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
histamine receptor H 2 TROGLITAZONE Histamine H2 62% NoneNone NoneNone View